Advisornet Financial’s Orchestra BioMed OBIO Stock Holding History

Advisornet Financial’s Portfolio OBIO Stock Details OBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.32K	Hold	1,696	–	–	﹤0.01%	1677
2026 Q1	$7.21K	Buy	+1,696	New	+$7.22K	﹤0.01%	1638

Other funds holding OBIO

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Advisornet Financial's OBIO Position: Q2 2026 in Review

Advisornet Financial held its Orchestra BioMed (OBIO) position steady in Q2 2026 at 1,696 shares worth $7.32K. The position accounts for ﹤0.01% of the portfolio, ranked #1677.

Advisornet Financial first reported a position in OBIO in Q1 2026 and has held it in 2 quarters since. 77 funds tracked by Wall St. Rank hold OBIO as of Q2 2026.

Advisornet Financial held 1,696 shares of Orchestra BioMed worth $7.32K as of Q2 2026.
Advisornet Financial left its Orchestra BioMed share count unchanged in Q2 2026.
Orchestra BioMed made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #1677 holding.
Advisornet Financial first reported a position in Orchestra BioMed in Q1 2026 and has held it in 2 quarters since.
77 funds tracked by Wall St. Rank held Orchestra BioMed as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.